Interestingly, our date showed that increased MSH6 and PMS2 mRNA levels were correlated with a favorable OS in serous ovarian cancer, but not in endometrioid ovarian cancer. The gene discussed is MSH6; the disease is ovarian endometrioid adenocarcinoma.